Key result
CRISPR-mediated ApoE and LDLR double knockout markedly elevates atherogenic lipids in minipigs to model CVD.
Why the study?
A suitable pig model to study metabolic disorders and subsequent atherosclerosis is not currently available, and traditional diet-induced cardiovascular disease models are time consuming and laborious.
Answers are grounded in this paper and cite their sources.
CRISPR/Cas9-mediated double knockout of ApoE and LDLR in Bama minipigs successfully elevates atherogenic lipids, providing a novel large animal model for cardiovascular disease research.
// Lei Huang 1, 3 , Zaidong Hua 2 , Hongwei Xiao 2 , Ying Cheng 1 , Kui Xu 1 , Qian Gao 1 , Ying Xia 1 , Yang Liu 1 , Xue Zhang 1 , Xinming Zheng 2 , Yulian Mu 1 and Kui Li 1 1 State Key Laboratory of Animal Nutrition, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China 2 Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding, Institute of Animal Science and Veterinary Medicine, Hubei Academy of Agricultural Science, Wuhan 430064, China 3 Animal Functional Genomics Group, Agricultural Genomes Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen 518120, China Correspondence to: Yulian Mu, email: mouyulian@caas.cn Keywords: cardiovascular disease, dyslipidemia, animal model, multiple-gene knockout, gene editing Received: September 06, 2016 Accepted: March 28, 2017 Published: April 17, 2017 ABSTRACT The traditional method to establish a cardiovascular disease model induced by high fat and high cholesterol diets is time consuming and laborious and may not be appropriate in all circumstances. A suitable pig model to study metabolic disorders and subsequent atherosclerosis is not currently available. For this purpose, we applied the CRISPR/Cas9 system to Bama minipigs, targeting apolipoprotein E (ApoE) and low density lipoprotein receptor (LDLR) gene simultaneously. Six biallelic knockout pigs of these two genes were obtained successfully in a single step. No off-target incidents or mosaic mutations were detected by an unbiased analysis. Serum biochemical analyses of gene-modified piglets showed that the levels of low density lipoprotein choleserol (LDL-C), total cholesterol (TC) and apolipoprotein B (APOB) were elevated significantly. This model should prove valuable for the study of human cardiovascular disease and related translational research.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2017) studied Cardiovascular disease model (n=6). CRISPR/Cas9-mediated ApoE and LDLR double gene knockout was evaluated on Serum levels of LDL-C, TC, and APOB. CRISPR/Cas9-mediated ApoE and LDLR double gene knockout in Bama minipigs successfully elevated serum levels of LDL-C, total cholesterol, and apolipoprotein B to model cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: